Broad Institute is empowering a revolution in biomedicine to accelerate the pace at which the world conquers disease
Propelling the understanding and treatment of disease
Collaborating deeply
Broad Institute is a mission-driven community that brings together researchers in medicine, biology, chemistry, computation, engineering, and mathematics from across MIT, Harvard, and Harvard-affiliated hospitals, along with collaborators around the world
Reaching globally
Broad Institute is committed to addressing medical challenges across the world, including collaborating with scientists and public health experts to address important needs in developing countries
Empowering scientists
Broad Institute fosters an environment in which scientists can take risks on bold ideas with transformative potential
Building partnerships
Broad Institute works to build and sustain international consortia to speed discovery in areas including psychiatric research, infectious disease, cardiovascular disease, and cancer
Promoting inclusion
Broad Institute believes that progress in biomedical research requires a fully inclusive community across sex, race, ethnicity, sexual orientation, age, and gender identity
INSIDE BROAD
News / 05.22.19
Scientists identify new genetic targets for disease research and potentially drug development.Read more
News / 05.10.19
Researchers take a broad, multi-faceted look at a large collection of cancer cell lines, creating a new trove of data to explore for drug development opportunities.Read more
News / 05.24.19
Rare diabetes variants revealed, blood stem cells' neighborhood mapped, base editors' scope expanded, and more.Read more
News / 05.2.19
New tool identifies compounds that inhibit CRISPR-Cas enzymes, enabling more precise and efficient CRISPR technologiesRead more
News / 05.10.19
Study in cell models and mice suggests that limiting oxygen could control symptoms of Friedreich’s ataxia, though more work is needed to demonstrate safetyRead more
News / 04.18.19
Powerful new tool may enable new opportunities for biological understanding and clinical interventionsRead more
News / 05.2.19
Neurobiologist and drug developer returns to academia to help guide the Broad’s psychiatric researchRead more
News / 05.7.19
Agreement enables development of genome-based therapies to protect against heart disease in adultsRead more
Blog / 04.16.19
A Broad chemist talks about his experiences on a team guiding a new targeted cancer treatment to the clinic.Read more
News / 04.10.19
Cancer cells that cannot repair a certain form of DNA mutation become strongly dependent on single enzyme to survive, creating a new potential opportunity for drug development.Read more
News / 03.29.19
Diversifying population-level genetic data beyond Europeans will expand the power of polygenic scores.Read more
Blog / 05.16.19
In a #WhyIScience Q&A, the longtime group leader from the Broad’s Cancer Program recounts his move from molecular to computational biology and talks about the collaborative effort that went into...Read more
Blog / 03.18.19
In a #WhyIScience Q&A, the postdoctoral fellow, who is a computer scientist by training, explains how she ended up working in the biomedical field, bringing math and computational power to bear...Read more
Events / 03.5.19
Join us at this public event celebrating women’s history month in a conversation about art and science.Read more